Clinical Trial Update: Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating Ablation Therapy for intermediate-risk non-muscle invasive bladder cancer. The study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Ablation Therapy

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Non-muscle Invasive Bladder Cancer (NMIBC) | Phase 2 | Status: NOT_YET_RECRUITING